Recent content by mpanju

CEO Jan Alenfall comments: “We are very pleased to have completed this phase IIa clinical study that has shown that the treatment is safe and despite the limited number of patients, also shows a good effect on hair growth. The highest dose showed that the treatment resulted in both increased...

The ARM Cell & Gene Investor Day was held on April 17, 2018 in New York; Dr. Stephen Chang presented. Histogen's presentation (YouTube) There are also two upcoming conferences but Dr. Chang seems to have disclosed the most up to date information: Skin Care Conference & Expo Montreal, Canada...

Kinda astonishing that Follica's website has been up for a while and no one seemingly noticed the part of the site that describes the In home treatment that clearly says...(emphasis mine) Our at-home treatment system is being designed to better deliver a range of compounds directly to the scalp...

Wanna know a company that really stretched out a timeline? Histogen. A lot of folks were planning a Mexico trip this year....

Hey @joshua, how has your experience with MinoxidilMax been? I am assuming that it's not been like Xandrox? I am currently on 05.mg Dutasteride every alternate day but my hairline has been taking a hit of late and so I am considering adding the DualGen-15 and dermarolling weekly with a 1.5mm as...

So it would seem that initiating the pivotal trial includes whatever is required to get it ready and it actually begins in the second half of 2018!

I read that with Sheldon Cooper's voice in my head :Do_O

Dig a bit deeper... minoxidil + a host of other potential agents... [0065] In particular aspects, the hair growth-promoting agent used in accordance with this aspect enhances conversion of vellus hair to nonvellus hair. In one such aspect, the hair growth-promoting agent enhances conversion of...

To quote from the SEC directly, Form 8-K is the “current report” companies must file with the SEC to announce major events that shareholders should know about.

Thought I'd just drop the latest 8K filed by PolarityTE right here! In summary...

Well how abow dah

Spot on that was really a great interview outlining Replicel's vision with this treatment. Some of us are getting our knickers in a twist far too easily. Let's just wait for the data, personally I am excited to hear about the data and how it builds on much more data points than the original 16...